VDAC1 and cancer: Importantly, we have been able to develop VDAC1-based peptides, which can interfere with these interactions, leading to impaired cell metabolism and apoptosis (18–20, 70, 71) (see VDAC1-Based Peptides As Potential Anti-Cancer Therapy).